51 results
8-K
EX-1.1
SLNO
Soleno Therapeutics Inc
29 Sep 23
Entry into a Material Definitive Agreement
4:55pm
and contractual obligations relating to the privacy and security of IT Systems and Personal Data and to the protection of such IT Systems and Personal Data from … Data. To the Company’s knowledge, no person has commenced any proceedings relating to the Company’s or any Subsidiary’s information privacy or data
424B5
SLNO
Soleno Therapeutics Inc
29 Sep 23
Prospectus supplement for primary offering
4:51pm
and market, sell and distribute any products for which we obtain marketing approval. In addition, we may be subject to transparency laws and patient privacy … obligations, including mandatory contractual terms, with respect to safeguarding the privacy, security and transmission of individually identifiable health
424B5
SLNO
Soleno Therapeutics Inc
27 Sep 23
Prospectus supplement for primary offering
5:26pm
and patient privacy regulation by the federal government and by the U.S. states and foreign jurisdictions in which we conduct our business. The applicable … certain obligations, including mandatory contractual terms, with respect to safeguarding the privacy, security and transmission of individually
8-K
EX-1.1
vjg6lq732f0
30 Mar 22
Soleno Therapeutics Announces Pricing of Approximately $15 Million Underwritten Public Offering
5:24pm
424B5
f6xujvh9ocd7 sc
30 Mar 22
Prospectus supplement for primary offering
5:21pm
424B5
vrtd tbem0
28 Mar 22
Prospectus supplement for primary offering
4:53pm
8-K
EX-1.1
t5dg6a4v7cu
16 Jul 21
Entry into a Material Definitive Agreement
4:14pm
8-K
EX-1.1
tz13l839ly suz3fujj
26 Jun 20
Soleno Therapeutics Announces Pricing of $50 Million Public Offering of Common Stock
4:31pm
424B5
cbhz05yy6j2r1 xt
25 Jun 20
Prospectus supplement for primary offering
4:01pm
424B5
ixk0t0vcdmqm30kt97
23 Jun 20
Prospectus supplement for primary offering
4:06pm